Rare disease patients protection: theoretical discussion and institutional construction of orphan drug designation in China

Xiaopei Zhao, Mengyao Zhang

Open source

DOI
10.1186/s13023-026-04404-4
Published
2026-05-25
Container
Orphanet Journal of Rare Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13023-026-04404-4,
  title = {Rare disease patients protection: theoretical discussion and institutional construction of orphan drug designation in China},
  author = {Xiaopei Zhao and Mengyao Zhang},
  year = {2026},
  journal = {Orphanet Journal of Rare Diseases},
  doi = {10.1186/s13023-026-04404-4},
  url = {https://doi.org/10.1186/s13023-026-04404-4}
}

RIS

TY  - JOUR
TI  - Rare disease patients protection: theoretical discussion and institutional construction of orphan drug designation in China
AU  - Xiaopei Zhao
AU  - Mengyao Zhang
PY  - 2026
JO  - Orphanet Journal of Rare Diseases
DO  - 10.1186/s13023-026-04404-4
UR  - https://doi.org/10.1186/s13023-026-04404-4
ER  - 

APA

Zhao, X., & Zhang, M. (2026). Rare disease patients protection: theoretical discussion and institutional construction of orphan drug designation in China. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-026-04404-4

Source records